
TG Therapeutics, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals
2025-10-28 15:38:03TG Therapeutics, Inc. has recently revised its evaluation amid current market dynamics, with its stock showing a slight increase. Over the past year, the company has outperformed the S&P 500 significantly. Technical indicators present mixed signals, while the company has demonstrated strong long-term performance, particularly over three years.
Read MoreIs TG Therapeutics, Inc. technically bullish or bearish?
2025-10-28 11:38:29As of 24 October 2025, the technical trend for TG Therapeutics, Inc. has changed from sideways to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is mildly bearish. The daily moving averages also reflect a mildly bearish outlook. Bollinger Bands show a bearish signal on the weekly chart but are mildly bullish on the monthly. The KST and OBV are both mildly bullish on the weekly but mildly bearish on the monthly, and Dow Theory supports a mildly bearish view on the weekly while being mildly bullish on the monthly. Overall, the indicators suggest a mildly bearish stance, with no multi-period return data available for comparison to the S&P 500....
Read MoreIs TG Therapeutics, Inc. technically bullish or bearish?
2025-10-27 11:49:42As of 24 October 2025, the technical trend for TG Therapeutics, Inc. has changed from sideways to mildly bearish. The weekly MACD indicates a mildly bullish stance, but the monthly MACD is mildly bearish, suggesting mixed signals. The daily moving averages are mildly bearish, and the Bollinger Bands show a bearish trend on the weekly chart while being mildly bullish on the monthly. The KST and OBV both reflect a mildly bearish position on the weekly but mildly bullish on the monthly. In terms of performance, TG Therapeutics has underperformed the S&P 500 over the past week and month, with returns of -3.85% and -5.86% compared to the S&P 500's gains of 1.92% and 2.32%, respectively. However, it has outperformed the benchmark significantly over the longer term, with a 1-year return of 43.56% versus 16.90% for the S&P 500. Overall, the current technical stance is mildly bearish....
Read MoreIs TG Therapeutics, Inc. technically bullish or bearish?
2025-10-26 11:24:23As of 24 October 2025, the technical trend for TG Therapeutics, Inc. has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by daily moving averages and weekly indicators such as Dow Theory and OBV, both indicating a bearish sentiment. The MACD shows a mixed signal with a mildly bullish weekly reading but a mildly bearish monthly reading. The Bollinger Bands reflect a bearish weekly outlook while being mildly bullish monthly. In terms of performance, TG Therapeutics has underperformed the S&P 500 over the past week and month, with returns of -3.85% and -5.86% compared to the S&P 500's gains of 1.92% and 2.32%, respectively. However, it has outperformed the benchmark over the longer term, with a 1-year return of 43.56% versus the S&P 500's 16.90%....
Read More
TG Therapeutics, Inc. Experiences Revision in Stock Evaluation Amid Strong Performance Metrics
2025-10-07 20:23:48TG Therapeutics, Inc. has recently revised its evaluation amid current market dynamics, with its stock showing a slight increase. Over the past year, the company has achieved a notable return of 65.36%, significantly outperforming the S&P 500. Technical indicators present a mixed outlook, reflecting both bullish and bearish trends.
Read MoreIs TG Therapeutics, Inc. technically bullish or bearish?
2025-10-06 12:00:34As of 3 October 2025, the technical trend for TG Therapeutics, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed indicators influencing the outlook. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish. Bollinger Bands are bullish on both weekly and monthly time frames. Moving averages indicate a mildly bearish trend on a daily basis, while the KST is bearish on both weekly and monthly time frames. Dow Theory shows a mildly bullish stance on both time frames, and the OBV is also mildly bullish weekly and monthly. Overall, the indicators suggest a lack of strong momentum in either direction. Return data is not available for comparison with the S&P 500....
Read MoreIs TG Therapeutics, Inc. technically bullish or bearish?
2025-10-05 11:45:14As of 3 October 2025, the technical trend for TG Therapeutics, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across various indicators. The MACD shows a mildly bullish signal on the weekly chart but is mildly bearish on the monthly. The Bollinger Bands indicate bullishness on both weekly and monthly time frames. However, moving averages are mildly bearish on the daily chart, and the KST is bearish on both weekly and monthly charts. Despite the mixed indicators, the Dow Theory suggests a mildly bullish stance on both weekly and monthly levels, supported by a mildly bullish OBV. In terms of performance, TG Therapeutics has significantly outperformed the S&P 500 across multiple periods, with a 1-year return of 65.41% compared to the S&P 500's 17.82%....
Read More
TG Therapeutics Hits Day High with Strong 8.03% Intraday Surge
2025-09-23 15:02:50TG Therapeutics, Inc. has shown notable stock activity, driven by strong financial performance, including a significant net profit growth and record quarterly net sales. The company maintains high institutional holdings and has consistently outperformed the S&P 500, reflecting its stability and growth potential in the Pharmaceuticals & Biotechnology sector.
Read MoreIs TG Therapeutics, Inc. technically bullish or bearish?
2025-09-20 19:19:00As of 21 August 2025, the technical trend for TG Therapeutics, Inc. has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven by a bearish MACD on the weekly timeframe and a mildly bearish signal on the daily moving averages. The KST is bearish on the weekly but bullish on the monthly, indicating mixed signals. The Bollinger Bands show a mildly bearish trend on the weekly but bullish on the monthly, adding to the complexity of the current technical picture. In terms of performance, TG Therapeutics has outperformed the S&P 500 over the past year with a return of 29.15% compared to the S&P's 17.14%, but it lags behind the S&P over the 5-year period, returning 24.70% versus the S&P's 96.61%....
Read More





